Nathaniel E. Eraikhuemen to Humans
This is a "connection" page, showing publications Nathaniel E. Eraikhuemen has written about Humans.
Connection Strength
0.161
-
Richter LM, Soric MM, Hilaire ML, Kawahara NE, Eraikhuemen N. Integrating professional identity formation into experiential pharmacy education and training. Am J Health Syst Pharm. 2024 Jan 01; 81(1):e49-e52.
Score: 0.044
-
Eraikhuemen N, Leung S, Warren SB, Lazaridis D, Smith CH, Kearson ML, Marcellus V. Effects of the Sodium-Glucose Cotransporter Inhibitors on Cardiovascular Death and All-Cause Mortality: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Clinical Trials. Am J Cardiovasc Drugs. 2023 Mar; 23(2):113-126.
Score: 0.041
-
Lazaridis D, Leung S, Kohler L, Smith CH, Kearson ML, Eraikhuemen N. The Impact of Anticoagulation on COVID-19 (SARS CoV-2) Patient Outcomes: A Systematic Review. J Pharm Pract. 2022 Dec; 35(6):1000-1006.
Score: 0.037
-
Eraikhuemen N, Lazaridis D, Dutton MT. Emerging Pharmacotherapy to Reduce Elevated Lipoprotein(a) Plasma Levels. Am J Cardiovasc Drugs. 2021 May; 21(3):255-265.
Score: 0.037
-
Rappa LR, Larose-Pierre M, Payne DR, Eraikhuemen NE, Lanes DM, Kearson ML. Detoxification from high-dose zolpidem using diazepam. Ann Pharmacother. 2004 Apr; 38(4):590-4.
Score: 0.003